Type |
Details |
Score |
Publication |
First Author: |
Chen L |
Year: |
1998 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. |
Volume: |
95 |
Issue: |
1 |
Pages: |
195-200 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saucedo LJ |
Year: |
1998 |
Journal: |
Cell Growth Differ |
Title: |
Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation. |
Volume: |
9 |
Issue: |
2 |
Pages: |
119-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pant V |
Year: |
2011 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. |
Volume: |
108 |
Issue: |
29 |
Pages: |
11995-2000 |
|
•
•
•
•
•
|
Publication |
First Author: |
Klimovich B |
Year: |
2020 |
Journal: |
Cell Cycle |
Title: |
Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo. |
Volume: |
19 |
Issue: |
1 |
Pages: |
109-123 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sashida G |
Year: |
2009 |
Journal: |
Mol Cell Biol |
Title: |
ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation. |
Volume: |
29 |
Issue: |
13 |
Pages: |
3687-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Francoz S |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. |
Volume: |
103 |
Issue: |
9 |
Pages: |
3232-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiong S |
Year: |
2006 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. |
Volume: |
103 |
Issue: |
9 |
Pages: |
3226-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Van Alstyne M |
Year: |
2018 |
Journal: |
Genes Dev |
Title: |
Dysregulation of Mdm2 and Mdm4 alternative splicing underlies motor neuron death in spinal muscular atrophy. |
Volume: |
32 |
Issue: |
15-16 |
Pages: |
1045-1059 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carr MI |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis. |
Volume: |
16 |
Issue: |
10 |
Pages: |
2618-2629 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lin HK |
Year: |
2002 |
Journal: |
EMBO J |
Title: |
Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. |
Volume: |
21 |
Issue: |
15 |
Pages: |
4037-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Batuello CN |
Year: |
2015 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase. |
Volume: |
112 |
Issue: |
6 |
Pages: |
1749-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wienken M |
Year: |
2016 |
Journal: |
Mol Cell |
Title: |
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53. |
Volume: |
61 |
Issue: |
1 |
Pages: |
68-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo W |
Year: |
2018 |
Journal: |
Biochim Biophys Acta Mol Cell Res |
Title: |
MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease. |
Volume: |
1865 |
Issue: |
8 |
Pages: |
1034-1045 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu D |
Year: |
2015 |
Journal: |
J Biol Chem |
Title: |
Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β. |
Volume: |
290 |
Issue: |
16 |
Pages: |
10200-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chandler DS |
Year: |
2006 |
Journal: |
Cancer Res |
Title: |
Genotoxic stress induces coordinately regulated alternative splicing of the p53 modulators MDM2 and MDM4. |
Volume: |
66 |
Issue: |
19 |
Pages: |
9502-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yin C |
Year: |
2011 |
Journal: |
Mol Biol Cell |
Title: |
Intact MDM2 E3 ligase activity is required for the cytosolic localization and function of β-arrestin2. |
Volume: |
22 |
Issue: |
9 |
Pages: |
1608-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saucedo LJ |
Year: |
1999 |
Journal: |
J Biol Chem |
Title: |
Multiple murine double minute gene 2 (MDM2) proteins are induced by ultraviolet light. |
Volume: |
274 |
Issue: |
12 |
Pages: |
8161-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alkhalaf M |
Year: |
1999 |
Journal: |
Oncogene |
Title: |
MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice. |
Volume: |
18 |
Issue: |
7 |
Pages: |
1419-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mulay SR |
Year: |
2012 |
Journal: |
Kidney Int |
Title: |
MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. |
Volume: |
81 |
Issue: |
12 |
Pages: |
1199-211 |
|
•
•
•
•
•
|
Publication |
First Author: |
Song H |
Year: |
2019 |
Journal: |
Int J Cancer |
Title: |
GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development. |
Volume: |
144 |
Issue: |
4 |
Pages: |
777-787 |
|
•
•
•
•
•
|
Publication |
First Author: |
Volk EL |
Year: |
2009 |
Journal: |
Dis Model Mech |
Title: |
MDM2-A, a common Mdm2 splice variant, causes perinatal lethality, reduced longevity and enhanced senescence. |
Volume: |
2 |
Issue: |
1-2 |
Pages: |
47-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mendrysa SM |
Year: |
2003 |
Journal: |
Mol Cell Biol |
Title: |
mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. |
Volume: |
23 |
Issue: |
2 |
Pages: |
462-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu DC |
Year: |
2017 |
Journal: |
Hum Mol Genet |
Title: |
Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity. |
Volume: |
26 |
Issue: |
20 |
Pages: |
3895-3908 |
|
•
•
•
•
•
|
Publication |
First Author: |
Eischen CM |
Year: |
2004 |
Journal: |
Oncogene |
Title: |
Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development. |
Volume: |
23 |
Issue: |
55 |
Pages: |
8931-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jung CR |
Year: |
2010 |
Journal: |
J Clin Invest |
Title: |
Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. |
Volume: |
120 |
Issue: |
12 |
Pages: |
4493-506 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wu KK |
Year: |
2024 |
Journal: |
Nat Commun |
Title: |
MDM2 induces pro-inflammatory and glycolytic responses in M1 macrophages by integrating iNOS-nitric oxide and HIF-1α pathways in mice. |
Volume: |
15 |
Issue: |
1 |
Pages: |
8624 |
|
•
•
•
•
•
|
Publication |
First Author: |
Reinke V |
Year: |
1997 |
Journal: |
Oncogene |
Title: |
The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo. |
Volume: |
15 |
Issue: |
13 |
Pages: |
1527-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Terzian T |
Year: |
2008 |
Journal: |
Genes Dev |
Title: |
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. |
Volume: |
22 |
Issue: |
10 |
Pages: |
1337-44 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tian H |
Year: |
2017 |
Journal: |
J Biol Chem |
Title: |
Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice. |
Volume: |
292 |
Issue: |
52 |
Pages: |
21614-21622 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang J |
Year: |
2021 |
Journal: |
Cancer Res |
Title: |
MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation In Vivo. |
Volume: |
81 |
Issue: |
4 |
Pages: |
898-909 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alt JR |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair. |
Volume: |
280 |
Issue: |
19 |
Pages: |
18771-81 |
|
•
•
•
•
•
|
Publication |
First Author: |
Barak Y |
Year: |
1994 |
Journal: |
Genes Dev |
Title: |
Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. |
Volume: |
8 |
Issue: |
15 |
Pages: |
1739-49 |
|
•
•
•
•
•
|
Publication |
First Author: |
Abbas HA |
Year: |
2010 |
Journal: |
Cell Stem Cell |
Title: |
Mdm2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. |
Volume: |
7 |
Issue: |
5 |
Pages: |
606-17 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fakharzadeh SS |
Year: |
1991 |
Journal: |
EMBO J |
Title: |
Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. |
Volume: |
10 |
Issue: |
6 |
Pages: |
1565-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gannon HS |
Year: |
2012 |
Journal: |
Cancer Cell |
Title: |
ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice. |
Volume: |
21 |
Issue: |
5 |
Pages: |
668-79 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2014 |
Journal: |
Dev Biol |
Title: |
Aberrant activation of p53 due to loss of MDM2 or MDMX causes early lens dysmorphogenesis. |
Volume: |
396 |
Issue: |
1 |
Pages: |
19-30 |
|
•
•
•
•
•
|
Publication |
First Author: |
Eischen CM |
Year: |
2012 |
Journal: |
PLoS One |
Title: |
Decreased Mdm2 expression inhibits tumor development and extends survival independent of Arf and dependent on p53. |
Volume: |
7 |
Issue: |
9 |
Pages: |
e46148 |
|
•
•
•
•
•
|
Publication |
First Author: |
Beauchamp MC |
Year: |
2021 |
Journal: |
Hum Mol Genet |
Title: |
Mutation in Eftud2 causes craniofacial defects in mice via mis-splicing of Mdm2 and increased P53. |
Volume: |
30 |
Issue: |
9 |
Pages: |
739-757 |
|
•
•
•
•
•
|
Publication |
First Author: |
McDonnell TJ |
Year: |
1999 |
Journal: |
J Pathol |
Title: |
Loss of one but not two mdm2 null alleles alters the tumour spectrum in p53 null mice. |
Volume: |
188 |
Issue: |
3 |
Pages: |
322-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Daujat S |
Year: |
2001 |
Journal: |
Mech Dev |
Title: |
Preferential expression of Mdm2 oncogene during the development of neural crest and its derivatives in mouse early embryogenesis. |
Volume: |
103 |
Issue: |
1-2 |
Pages: |
163-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sui P |
Year: |
2019 |
Journal: |
Development |
Title: |
E3 ubiquitin ligase MDM2 acts through p53 to control respiratory progenitor cell number and lung size. |
Volume: |
146 |
Issue: |
24 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hilliard S |
Year: |
2011 |
Journal: |
Dev Biol |
Title: |
Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching. |
Volume: |
353 |
Issue: |
2 |
Pages: |
354-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Itahana K |
Year: |
2007 |
Journal: |
Cancer Cell |
Title: |
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. |
Volume: |
12 |
Issue: |
4 |
Pages: |
355-66 |
|
•
•
•
•
•
|
Publication |
First Author: |
Frum RA |
Year: |
2014 |
Journal: |
Nucleic Acids Res |
Title: |
The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing. |
Volume: |
42 |
Issue: |
2 |
Pages: |
926-40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iwakuma T |
Year: |
2004 |
Journal: |
Oncogene |
Title: |
Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null mice. |
Volume: |
23 |
Issue: |
46 |
Pages: |
7644-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Parant J |
Year: |
2001 |
Journal: |
Nat Genet |
Title: |
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. |
Volume: |
29 |
Issue: |
1 |
Pages: |
92-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Qin Q |
Year: |
2010 |
Journal: |
PLoS One |
Title: |
Cholesterol Perturbation in Mice Results in p53 Degradation and Axonal Pathology through p38 MAPK and Mdm2 Activation. |
Volume: |
5 |
Issue: |
4 |
Pages: |
e9999 |
|
•
•
•
•
•
|
Publication |
First Author: |
Stanley-Hasnain S |
Year: |
2017 |
Journal: |
Cell Cycle |
Title: |
p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs. |
Volume: |
16 |
Issue: |
17 |
Pages: |
1585-1600 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hauck L |
Year: |
2017 |
Journal: |
PLoS One |
Title: |
Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death. |
Volume: |
12 |
Issue: |
12 |
Pages: |
e0189861 |
|
•
•
•
•
•
|
Publication |
First Author: |
Midgley CA |
Year: |
1997 |
Journal: |
Oncogene |
Title: |
p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. |
Volume: |
15 |
Issue: |
10 |
Pages: |
1179-89 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Q |
Year: |
2012 |
Journal: |
J Pathol |
Title: |
Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development. |
Volume: |
228 |
Issue: |
3 |
Pages: |
416-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Marine JC |
Year: |
2006 |
Journal: |
Cell Death Differ |
Title: |
Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. |
Volume: |
13 |
Issue: |
6 |
Pages: |
927-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Langenbach M |
Year: |
2023 |
Journal: |
Mol Cancer Res |
Title: |
MDM2 inhibition enhances immune checkpoint inhibitor efficacy by increasing IL-15 and MHC class II production. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Kamio T |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis. |
Volume: |
11 |
Issue: |
4 |
Pages: |
e0152263 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang Y |
Year: |
2017 |
Journal: |
Dev Biol |
Title: |
Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner. |
Volume: |
423 |
Issue: |
1 |
Pages: |
34-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ringshausen I |
Year: |
2006 |
Journal: |
Cancer Cell |
Title: |
Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. |
Volume: |
10 |
Issue: |
6 |
Pages: |
501-14 |
|
•
•
•
•
•
|
Publication |
First Author: |
Montes de Oca Luna R |
Year: |
1997 |
Journal: |
Nat Genet |
Title: |
Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality. |
Volume: |
16 |
Issue: |
4 |
Pages: |
336-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chibaya L |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis. |
Volume: |
118 |
Issue: |
4 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Zhao R |
Year: |
2011 |
Journal: |
J Clin Invest |
Title: |
Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. |
Volume: |
121 |
Issue: |
3 |
Pages: |
851-65 |
|
•
•
•
•
•
|
Publication |
First Author: |
Carr MI |
Year: |
2016 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice. |
Volume: |
113 |
Issue: |
52 |
Pages: |
15024-15029 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tollini LA |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. |
Volume: |
26 |
Issue: |
2 |
Pages: |
235-47 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7531830 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2023-10-04 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3288928 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:7532832 |
Age: |
postnatal day 14 |
Image: |
7Fd |
Note: |
Proximity ligation assay indicated that the interaction between MDM2 and DLX3 was enhanced in the secretory odontoblasts. |
Specimen Label: |
7Fd |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:7531830 |
Assay Type: |
Immunohistochemistry |
Annotation Date: |
2023-10-04 |
Strength: |
Weak |
Sex: |
Not Specified |
Emaps: |
EMAPS:3289428 |
Pattern: |
Regionally restricted |
Stage: |
TS28 |
Assay Id: |
MGI:7532832 |
Age: |
postnatal day 14 |
Image: |
7Fc |
Note: |
Proximity ligation assay indicated that the interaction between MDM2 and DLX3 was weak in undifferentiated dental mesenchymal cells. |
Specimen Label: |
7Fc |
Detected: |
true |
Specimen Num: |
1 |
|
•
•
•
•
•
|
Publication |
First Author: |
Volk EL |
Year: |
2009 |
Journal: |
Mol Cancer Res |
Title: |
The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis. |
Volume: |
7 |
Issue: |
6 |
Pages: |
863-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Thisse C |
Year: |
2000 |
Journal: |
Differentiation |
Title: |
The Mdm2 gene of zebrafish (Danio rerio): preferential expression during development of neural and muscular tissues, and absence of tumor formation after overexpression of its cDNA during early embryogenesis. |
Volume: |
66 |
Issue: |
2-3 |
Pages: |
61-70 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhu D |
Year: |
2015 |
Journal: |
J Clin Invest |
Title: |
BAI1 regulates spatial learning and synaptic plasticity in the hippocampus. |
Volume: |
125 |
Issue: |
4 |
Pages: |
1497-508 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bizen N |
Year: |
2022 |
Journal: |
Cell Death Differ |
Title: |
Ddx20, an Olig2 binding factor, governs the survival of neural and oligodendrocyte progenitor cells via proper Mdm2 splicing and p53 suppression. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Fernandez K |
Year: |
2010 |
Journal: |
Am J Pathol |
Title: |
Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. |
Volume: |
176 |
Issue: |
1 |
Pages: |
416-34 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sasaki M |
Year: |
2011 |
Journal: |
Nat Med |
Title: |
Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. |
Volume: |
17 |
Issue: |
8 |
Pages: |
944-51 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
162
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
dog, domestic |
|
•
•
•
•
•
|
Gene |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chimpanzee |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
cattle |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
chicken |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
zebrafish |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
macaque, rhesus |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, western clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, African clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, African clawed |
|
•
•
•
•
•
|
Gene |
Type: |
gene |
Organism: |
frog, African clawed |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
440
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Q |
Year: |
2014 |
Journal: |
Mol Cancer Res |
Title: |
Therapeutic efficacy of p53 restoration in Mdm2-overexpressing tumors. |
Volume: |
12 |
Issue: |
6 |
Pages: |
901-11 |
|
•
•
•
•
•
|
HT Experiment |
|
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
UniProt Feature |
Begin: |
1 |
Description: |
E3 ubiquitin-protein ligase Mdm2 |
Type: |
chain |
End: |
489 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wasylishen AR |
Year: |
2018 |
Journal: |
Mol Cancer Res |
Title: |
Daxx Functions Are p53-Independent In Vivo. |
Volume: |
16 |
Issue: |
10 |
Pages: |
1523-1529 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mendrysa SM |
Year: |
2006 |
Journal: |
Genes Dev |
Title: |
Tumor suppression and normal aging in mice with constitutively high p53 activity. |
Volume: |
20 |
Issue: |
1 |
Pages: |
16-21 |
|
•
•
•
•
•
|
Publication |
First Author: |
Nasir L |
Year: |
2000 |
Journal: |
Cancer Lett |
Title: |
Cloning, sequence analysis and expression of the cDNAs encoding the canine and equine homologues of the mouse double minute 2 (mdm2) proto-oncogene. |
Volume: |
152 |
Issue: |
1 |
Pages: |
9-13 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xirodimas DP |
Year: |
2002 |
Journal: |
FEBS Lett |
Title: |
P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2. |
Volume: |
528 |
Issue: |
1-3 |
Pages: |
207-11 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
MDM2 is an oncoprotein that acts as a cellular inhibitor of the p53 tumour suppressor by binding to the transactivation domain of p53 and suppressing its ability to activate transcription []. In addition, MDM2 acts as an E3 ubiquitin ligase responsible for the ubiquitination and subsequent degradation of p53 []. P53 acts in response to DNA damage, inducing cell cycle arrest and apoptosis. Inactivation of p53 is a common occurrence in neoplastic transformations. MDM2 is also known to have p53-independent functions.The core of MDM2 folds into an open bundle of four helices that is capped by two small 3-stranded β-sheets. It consists of a duplication of two structural repeats. MDM2 has a deep hydrophobic cleft on which the p53 α-helix binds; p53 residues involved in transactivation are buried deep within the cleft of MDM2, thereby concealing the p53 transactivation domain. In addition to its N-terminal p53 binding domain, MDM2 contains a central acidic domain, zinc finger domain and a C-terminal RING-finger domain. |
|
•
•
•
•
•
|
Publication |
First Author: |
Piette J |
Year: |
1997 |
Journal: |
Oncogene |
Title: |
Mdm2: keeping p53 under control. |
Volume: |
15 |
Issue: |
9 |
Pages: |
1001-10 |
|
•
•
•
•
•
|
Publication |
First Author: |
Momand J |
Year: |
2000 |
Journal: |
Gene |
Title: |
MDM2--master regulator of the p53 tumor suppressor protein. |
Volume: |
242 |
Issue: |
1-2 |
Pages: |
15-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Oliner JD |
Year: |
1992 |
Journal: |
Nature |
Title: |
Amplification of a gene encoding a p53-associated protein in human sarcomas. |
Volume: |
358 |
Issue: |
6381 |
Pages: |
80-3 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dobbelstein M |
Year: |
1999 |
Journal: |
Oncogene |
Title: |
Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. |
Volume: |
18 |
Issue: |
12 |
Pages: |
2101-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
Guo CS |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1. |
Volume: |
278 |
Issue: |
25 |
Pages: |
22615-22 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shimizu H |
Year: |
2006 |
Journal: |
Biochem J |
Title: |
Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo. |
Volume: |
397 |
Issue: |
2 |
Pages: |
355-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mulay SR |
Year: |
2013 |
Journal: |
J Pathol |
Title: |
Podocyte loss involves MDM2-driven mitotic catastrophe. |
Volume: |
230 |
Issue: |
3 |
Pages: |
322-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
AlQarni S |
Year: |
2018 |
Journal: |
Oncogene |
Title: |
Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. |
Volume: |
37 |
Issue: |
29 |
Pages: |
3998-4012 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piccinin S |
Year: |
2012 |
Journal: |
Cancer Cell |
Title: |
A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation. |
Volume: |
22 |
Issue: |
3 |
Pages: |
404-15 |
|
•
•
•
•
•
|
Publication |
First Author: |
Paitel E |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation. |
Volume: |
278 |
Issue: |
12 |
Pages: |
10061-6 |
|
•
•
•
•
•
|